StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Zydus Lifesciences Limited
NSE:ZYDUSLIFE.NS
Sector
Location
Market Cap
USD 11.83 B
Share Price
USD 11.83
Avg Daily Volume
1,461,866
Change (1 day)
1.00%
Change (1 year)
-8.00%
Change (YTD)
4.18%
Zydus Lifesciences Limited Shares (Diluted, Weighted) for the year ending March 31, 2025: 1,006,338,000
Zydus Lifesciences Limited Shares (Diluted, Weighted) is 1,006,338,000 for the year ending March 31, 2025, a -0.55% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
-
Zydus Lifesciences Limited Shares (Diluted, Weighted) for the year ending March 31, 2024 was 1,011,926,837, a -0.37% change year over year.
-
Zydus Lifesciences Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 1,015,649,871, a -0.79% change year over year.
-
Zydus Lifesciences Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 1,023,742,600, a 0.00% change year over year.
-
Zydus Lifesciences Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 1,023,742,600, a 0.00% change year over year.
Competitors
Mankind Pharma Limited
USD 26.87
MANKIND.NS
+0.15
0.57%
Ipsen S.A.
USD 122.07
IPN.PA
+2.91
2.44%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.63%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.01
-0.38%
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Thermo Fisher Scientific Inc.
USD 421.47
TMO
+16.01
3.95%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
Key Data
| Date | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue |
|---|
Competitors
Mankind Pharma Limited
USD 26.87
MANKIND.NS
+0.15
0.57%
Ipsen S.A.
USD 122.07
IPN.PA
+2.91
2.44%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.63%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.01
-0.38%
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Thermo Fisher Scientific Inc.
USD 421.47
TMO
+16.01
3.95%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%